Alkermes (ALKS) Receivables - Net (2011 - 2026)
Alkermes (ALKS) posted quarterly Receivables - Net of $456.5 million for Q2 2026, up 28.62% year-over-year from $354.9 million in Q2 2025, and up 11.98% quarter-over-quarter from $407.6 million in Q1 2026.
Alkermes (ALKS) Receivables - Net (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Receivables - Net for 16 consecutive years, with $456.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Receivables - Net rose 28.62% year-over-year to $456.5 million; the TTM figure through Jun 2026 stood at $456.5 million (up 28.62% YoY), while the FY2025 annual figure was $334.0 million, down 13.13% from the prior year.
- Receivables - Net advanced to $456.5 million in Q2 2026 per ALKS's latest filing, from $407.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $456.5 million in Q2 2026 and bottomed at $706000.0 in Q4 2023.
- Historically, Receivables - Net has averaged $298.0 million across 5 years, with a median of $334.3 million in 2023.
- Annual changes were most pronounced in 2023 — Receivables - Net sank 92.09% — and 2024, when it surged 54365.72%.
- Alkermes' Receivables - Net stood at $8.9 million in 2022, then tumbled by 92.09% to $706000.0 in 2023, then soared by 54365.72% to $384.5 million in 2024, then declined by 13.13% to $334.0 million in 2025, then soared by 36.66% to $456.5 million in 2026.
- Business Quant data shows ALKS's Receivables - Net at $456.5 million in Q2 2026, $407.6 million in Q1 2026, and $334.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 456.48 Mn |
| Jun 30, 2026 | 456.48 Mn |
| Mar 31, 2026 | 407.63 Mn |
| Mar 31, 2026 | 407.63 Mn |
| Dec 31, 2025 | 334.03 Mn |
| Dec 31, 2025 | 334.03 Mn |
| Sep 30, 2025 | 354.39 Mn |
| Sep 30, 2025 | 354.39 Mn |
| Jun 30, 2025 | 354.91 Mn |
| Jun 30, 2025 | 354.91 Mn |
| Mar 31, 2025 | 318.70 Mn |
| Mar 31, 2025 | 318.70 Mn |
| Dec 31, 2024 | 384.53 Mn |
| Dec 31, 2024 | 384.53 Mn |
| Sep 30, 2024 | 367.21 Mn |
| Sep 30, 2024 | 367.21 Mn |
| Jun 30, 2024 | 366.42 Mn |
| Jun 30, 2024 | 366.42 Mn |
| Mar 31, 2024 | 315.85 Mn |
| Mar 31, 2024 | 315.85 Mn |